AllerFund Ventures (investor - Venture Capital)

See something wrong or missing? Let us know

Offices:New York

AllerFund is an American venture capital firm dedicated to driving social
impact for the food allergy community.

Average round investment:4.7M USD

Average number per year:1.0

Distribution: 2023 (1)

Portfolio companies: Belgium

Hippo Dx

Mostly invests in: Belgium

Belgium (1) Hardware (1)

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.